Collidion to buy 80% stake in Plex Pharmaceuticals

19:00 EDT 2 Aug 2017 | Pharmaceutical Technology

US-based healthcare company Collidion has entered a definitive agreement to purchase 80% equity stake in early stage biotechnology company Plex Pharmaceuticals for an undisclosed amount.

Original Article: Collidion to buy 80% stake in Plex Pharmaceuticals


More From BioPortfolio on "Collidion to buy 80% stake in Plex Pharmaceuticals"

Quick Search

Relevant Topics

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...